$MET · METLIFE INC
MetLife reported Q3 2026 results: net income of $2,351M ($3.67/share, +187% YoY) and adjusted earnings of $1,780M ($2.78/share, +12%). Adjusted EPS excluding total notable items rose 22% to $2.85, the highest-ever quarter. Total revenues reached $20,522M, up from $17,361M, with premiums, fees and other revenues up 12% to $14,056M. Book value per share fell 22% to $30.73 while adjusted BVPS rose 5% to $59.41. The company returned ~$1B to shareholders via buybacks and dividends.
- Net income rose 187% YoY to $2,351M, or $3.67 per share.
- Adjusted EPS ex-notable items hit a record $2.85, up 22% YoY.
- Premiums, fees and other revenues grew 12% to $14,056M.
- Book value per share fell 22% to $30.73; adjusted BVPS rose 5% to $59.41.
- Returned ~$1B to shareholders via buybacks and common dividends.
Extended-hours last trade $101.05, down 1.78% vs the $102.89 regular close, despite record adjusted EPS — suggesting profit-taking or concern over the 22% BVPS decline.
MetLife delivered its highest-ever quarterly adjusted EPS with top-line growth in every segment, yet shares slipped after hours on a 22% book value decline.
Strong variable investment income ($569M post-tax, above the $400M quarterly target) and broad-based volume growth across all six segments reflect favorable insurance-sector conditions.
Book value per share dropped 22% to $30.73, driven by market risk benefit remeasurement and derivative losses; net investment losses of $430M also weighed on results.